Transplantation of neural crest-like cells derived from induced pluripotent stem cells improves diabetic polyneuropathy in mice

Cell Transplantation

Volumn 22, Issue 10, 2013, Pages 1767-1783

  Okawa, Tetsuji ^a   Kamiya, Hideki ^a   Himeno, Tatsuhito ^a   Kato, Jiro ^a   Seino, Yusuke ^b   Fujiya, Atsushi ^a,b   Kondo, Masaki ^a   Tsunekawa, Shin ^a   Naruse, Keiko ^c   Hamada, Yoji ^b   Ozaki, Nobuaki ^d   Cheng, Zhao ^a   Kito, Tetsutaro ^a   Suzuki, Hirohiko ^a   Ito, Sachiko ^a   Oiso, Yutaka ^a   Nakamura, Jiro ^a,e   Isobe, Ken Ichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

^e AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Diabetic polyneuropathy (DPN); Induced pluripotent stem (iPS) cells; Neural crest (NC); Regenerative medicine

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR 2; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN RECEPTOR P75; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL LINEAGE; CONTROLLED STUDY; DIABETIC NEUROPATHY; EMBRYONIC STRUCTURES; FLUORESCENCE ACTIVATED CELL SORTING; GLIA CELL; HINDLIMB; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CONDUCTION; NERVE FIBER; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PERCEPTIVE THRESHOLD; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHWANN CELL; SKIN BLOOD FLOW; SMOOTH MUSCLE FIBER; SPINAL CORD BLOOD FLOW; STREPTOZOCIN DIABETES; VASCULAR SMOOTH MUSCLE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; FLOW CYTOMETRY; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NERVE FIBERS; NERVE GROWTH FACTOR; NEURAL CREST; NEURITES; RECEPTOR, NERVE GROWTH FACTOR; SCIATIC NERVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84877276466     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657710     Document Type: Article

References (65)

1. Aldskogius, H.; Berens, C.; Kanaykina, N.; Liakhovitskaia, A.; Medvinsky, A.; Sandelin, M.; Schreiner, S.; Wegner, M.; Hjerling-Leffler, J.; Kozlova, E. N. Regulation of boundary cap neural crest stem cell differentiation after transplantation. Stem Cells 27(7):1592-1603; 2009.
2. Alipio, Z.; Liao, W.; Roemer, E. J.; Waner, M.; Fink, L. M.; Ward, D. C.; Ma, Y. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic p-like cells. Proc. Natl. Acad. Sci. USA 107(30):13426-13431; 2010.
3. Apfel, S. C.; Kessler, J. A.; Adornato, B. T.; Litchy, W. J.; Sanders, C.; Rask, C. A. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group. Neurology 51(3):695-702; 1998.
4. Boulting, G. L.; Kiskinis, E.; Croft, G. F.; Amoroso, M. W.; Oakley, D. H.; Wainger, B. J.; Williams, D. J.; Kahler, D. J.; Yamaki, M.; Davidow, L.; Rodolfa, C. T.; Dimos, J. T.; Mikkilineni, S.; MacDermott, A. B.; Woolf, C. J.; Henderson, C. E.; Wichterle, H.; Eggan, K. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 29(3):279-286; 2011.
5. Boulton, A. J.; Vinik, A. I.; Arezzo, J. C.; Bril, V.; Feldman, E. L.; Freeman, R.; Malik, R. A.; Maser, R. E.; Sosenko, J. M.; Ziegler, D. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 28(4):956-962; 2005.
6. Bronner, M. E.; Ledouarin, N. M. Development and evolution of the neural crest: An overview. Dev. Biol. 366(1):2-9; 2012.
7. Callaghan, B. C.; Cheng, H. T.; Stables, C. L.; Smith, A. L.; Feldman, E. L. Diabetic neuropathy: Clinical manifestations and current treatments. Lancet Neurol. 11(6):521-534; 2012.
8. Cheng, H. T.; Dauch, J. R.; Hayes, J. M.; Yanik, B. M.; Feldman, E. L. Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes. Neurobiol. Dis. 45(1):280-287; 2012.
9. Cheng, Z.; Ito, S.; Nishio, N.; Xiao, H.; Zhang, R.; Suzuki, H.; Okawa, Y.; Murohara, T.; Isobe, K. I. Establishment of induced pluripotent stem cells from aged mice using bone marrow-derived myeloid cells. J. Mol. Cell. Biol. 3(2):91-98; 2011.
10. Drel, V. R.; Lupachyk, S.; Shevalye, H.; Vareniuk, I.; Xu, W.; Zhang, J.; Delamere, N. A.; Shahidullah, M.; Slusher, B.; Obrosova, I. G. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-n. Endocrinology 151(6):2547-2555; 2010.
11. Goss, J. R.; Goins, W. F.; Lacomis, D.; Mata, M.; Glorioso, J. C.; Fink, D. J. Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes 51(7):2227-2232; 2002.
12. Greene, D. A.; Sima, A. A.; Stevens, M. J.; Feldman, E. L.; Lattimer, S. A. Complications: Neuropathy, pathogenetic considerations. Diabetes Care 15(12):1902-1925; 1992.
13. Himeno, T.; Kamiya, H.; Naruse, K.; Harada, N.; Ozaki, N.; Seino, Y.; Shibata, T.; Kondo, M.; Kato, J.; Okawa, T.; Fukami, A.; Hamada, Y.; Inagaki, N.; Seino, Y.; Drucker, D. J.; Oiso, Y.; Nakamura, J. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice. Diabetes 60(9):2397-2406; 2011.
14. Huang, T. J.; Sayers, N. M.; Fernyhough, P.; Verkhratsky, A. Diabetes-induced alterations in calcium homeostasis in sensory neurones of streptozotocin-diabetic rats are restricted to lumbar ganglia and are prevented by neurotrophin-3. Diabetologia 45(4):560-570; 2002.
15. Ii, M.; Nishimura, H.; Kusano, K. F.; Qin, G.; Yoon, Y. S.; Wecker, A.; Asahara, T.; Losordo, D. W. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation 112(1):93-102; 2005.
16. Ito, Y.; Wiese, S.; Funk, N.; Chittka, A.; Rossoll, W.; Bömmel, H.; Watabe, K.; Wegner, M.; Sendtner, M. Sox10 regulates ciliary neurotrophic factor gene expression in Schwann cells. Proc. Natl. Acad. Sci. USA 103(20):7871-7876; 2006.
17. Jeong, J. O.; Kim, M. O.; Kim, H.; Lee, M. Y.; Kim, S. W.; Ii, M.; Lee, J. U.; Lee, J.; Choi, Y. J.; Cho, H. J.; Lee, N.; Silver, M.; Wecker, A.; Kim, D. W.; Yoon, Y. S. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 119(5):699-708; 2009.
18. Jiang, X.; Gwye, Y.; McKeown, S. J.; Bronner-Fraser, M.; Lutzko, C.; Lawlor, E. R. Isolation and characterization of neural crest stem cells derived from in vitro-differentiated human embryonic stem cells. Stem Cells Dev. 18(7):1059-1070; 2009.
19. Kamiya, D.; Banno, S.; Sasai, N.; Ohgushi, M.; Inomata, H.; Watanabe, K.; Kawada, M.; Yakura, R.; Kiyonari, H.; Nakao, K.; Jakt, L. M.; Nishikawa, S.; Sasai, Y. Intrinsic transition of embryonic stem-cell differentiation into neural progenitors. Nature 470(7335):503-509; 2011.
20. Kawasaki, H.; Mizuseki, K.; Nishikawa, S.; Kaneko, S.; Kuwana, Y.; Nakanishi, S.; Nishikawa, S. I.; Sasai, Y. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28(1):31-40; 2000.
21. Kim, H.; Park, J. S.; Choi, Y. J.; Kim, M. O.; Huh, Y. H.; Kim, S. W.; Han, J. W.; Lee, J.; Kim, S.; Houge, M. A.; Ii, M.; Yoon, Y. S. Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. Stem Cells 27(7):1686-1696; 2009.
22. Kinnaird, T.; Stabile, E.; Burnett, M. S.; Epstein, S. E. Bone-marrow-derived cells for enhancing collateral development: Mechanisms, animal data, and initial clinical experiences. Circ. Res. 95(4):354-363; 2004.
23. Kinnaird, T.; Stabile, E.; Burnett, M. S.; Shou, M.; Lee, C. W.; Barr, S.; Fuchs, S.; Epstein, S. E. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109(12):1543-1549; 2004.
24. Kitada, M.; Zhang, Z.; Mima, A.; King, G. Molecular mechanisms of diabetic vascular complications. J. Diabetes Invest. 1(3):77-89; 2010.
25. Kumagai, G.; Okada, Y.; Yamane, J.; Nagoshi, N.; Kitamura, K.; Mukaino, M.; Tsuji, O.; Fujiyoshi, K.; Katoh, H.; Okada, S.; Shibata, S.; Matsuzaki, Y.; Toh, S.; Toyama, Y.; Nakamura, M.; Okano, H. Roles of ES cell-derived gliogenic neural stem/progenitor cells in functional recovery after spinal cord injury. PLoS One 4(11):e7706; 2009.
26. Kusano, K. F.; Allendoerfer, K. L.; Munger, W.; Pola, R.; Bosch-Marce, M.; Kirchmair, R.; Yoon, Y. S.; Curry, C.; Silver, M.; Kearney, M.; Asahara, T.; Losordo, D. W. Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy. Arterioscler. Thromb. Vasc. Biol. 24(11):2102-2107; 2004.
27. Lee, G.; Kim, H.; Elkabetz, Y.; Al Shamy, G.; Panagiotakos, G.; Barberi, T.; Tabar, V.; Studer, L. Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat. Biotechnol. 25(12):1468-1475; 2007.
28. Lupachyk, S.; Shevalye, H.; Maksimchyk, Y.; Drel, V. R.; Obrosova, I. G. PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: Correlation with peripheral nerve function. Free Radic. Biol. Med. 50(10):1400-1409; 2011.
29. Masaki, I.; Yonemitsu, Y.; Yamashita, A.; Sata, S.; Tanii, M.; Komori, K.; Nakagawa, K.; Hou, X.; Nagai, Y.; Hasegawa, M.; Sugimachi, K.; Sueishi, K. Angiogenic gene therapy for experimental critical limb ischemia: Acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ. Res. 90(9):966-973; 2002.
30. Matsutomo, R.; Takebayashi, K.; Aso, Y. Assessment of peripheral neuropathy using measurement of the current perception threshold with the neurometer in patients with type 2 diabetes mellitus. J. Int. Med. Res. 33(4):442-453; 2005.
31. Mayshar, Y.; Ben-David, U.; Lavon, N.; Biancotti, J. C.; Yakir, B.; Clark, A. T.; Plath, K.; Lowry, W. E.; Benvenisty, N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7(4):521-531; 2010.
32. McMahon, A. P.; Bradley, A. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62(6):1073-1085; 1990.
33. Mizuseki, K.; Sakamoto, T.; Watanabe, K.; Muguruma, K.; Ikeya, M.; Nishiyama, A.; Arakawa, A.; Suemori, H.; Nakatsuji, N.; Kawasaki, H.; Murakami, F.; Sasai, Y. Generation of neural crest-derived peripheral neurons and floor plate cells from mouse and primate embryonic stem cells. Proc. Natl. Acad. Sci. USA 100(10):5828-5833; 2003.
34. Mudò, G.; Bonomo, A.; Di Liberto, V.; Frinchi, M.; Fuxe, K.; Belluardo, N. The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J. Neural. Transm. 116(8):995-1005; 2009.
35. Mundell, N. A.; Labosky, P. A. Neural crest stem cell multipotency requires Foxd3 to maintain neural potential and repress mesenchymal fates. Development 138(4):641-652; 2011.
36. Murakami, T.; Arai, M.; Sunada, Y.; Nakamura, A. VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice. J. Gene Med. 8(6):773-781; 2006.
37. Nagoshi, N.; Shibata, S.; Kubota, Y.; Nakamura, M.; Nagai, Y.; Satoh, E.; Morikawa, S.; Okada, Y.; Mabuchi, Y.; Katoh, H.; Okada, S.; Fukuda, K.; Suda, T.; Matsuzaki, Y.; Toyama, Y.; Okano, H. Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell 2(4):392-403; 2008.
38. Nakae, M.; Kamiya, H.; Naruse, K.; Horio, N.; Ito, Y.; Mizubayashi, R.; Hamada, Y.; Nakashima, E.; Akiyama, N.; Kobayashi, Y.; Watarai, A.; Kimura, N.; Horiguchi, M.; Tabata, Y.; Oiso, Y.; Nakamura, J. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes 55(5):1470-1477; 2006.
39. Naruse, K.; Hamada, Y.; Nakashima, E.; Kato, K.; Mizubayashi, R.; Kamiya, H.; Yuzawa, Y.; Matsuo, S.; Murohara, T.; Matsubara, T.; Oiso, Y.; Nakamura, J. Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 54(6):1823-1828; 2005.
40. Nelson, T. J.; Martinez-Fernandez, A.; Yamada, S.; Perez-Terzic, C.; Ikeda, Y.; Terzic, A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120(5):408-416; 2009.
41. Nishizawa, Y.; Wada, R.-I.; Baba, M.; Takeuchi, M.; Hanyu-Itabashi, C.; Yagihashi, S. Neuropathy induced by exogenously administered advanced glycation end-products in rats. J. Diabetes Invest. 1(1-2):40-49; 2010.
42. Obrosova, I. G. Diabetic painful and insensate neuropathy: Pathogenesis and potential treatments. Neurotherapeutics 6(4):638-647; 2009.
43. Sanchez, A.; Wadhwani, S.; Grammas, P. Multiple neurotrophic effects of VEGF on cultured neurons. Neuropeptides 44(4):323-331; 2010.
44. Satoh, J.; Yagihashi, S.; Baba, M.; Suzuki, M.; Arakawa, A.; Yoshiyama, T. Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebocontrolled trial. J. Diabetes Invest. 2(6):457-463; 2011.
45. Schratzberger, P.; Walter, D. H.; Rittig, K.; Bahlmann, F. H.; Pola, R.; Curry, C.; Silver, M.; Krainin, J. G.; Weinberg, D. H.; Ropper, A. H.; Isner, J. M. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest. 107(9):1083-1092; 2001.
46. Shibata, T.; Naruse, K.; Kamiya, H.; Kozakae, M.; Kondo, M.; Yasuda, Y.; Nakamura, N.; Ota, K.; Tosaki, T.; Matsuki, T.; Nakashima, E.; Hamada, Y.; Oiso, Y.; Nakamura, J. Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats. Diabetes 57(11):3099-3107; 2008.
47. Singh, R. P.; Cheng, Y. H.; Nelson, P.; Zhou, F. C. Retentive multipotency of adult dorsal root ganglia stem cells. Cell Transplant. 18(1):55-68; 2009.
48. Smith, A. G.; Russell, J.; Feldman, E. L.; Goldstein, J.; Peltier, A.; Smith, S.; Hamwi, J.; Pollari, D.; Bixby, B.; Howard, J.; Singleton, J. R. Lifestyle intervention for prediabetic neuropathy. Diabetes Care 29(6):1294-1299; 2006.
49. Smith, K. N.; Singh, A. M.; Dalton, S. Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell 7(3):343-354; 2010.
50. Son, E. Y.; Ichida, J. K.; Wainger, B. J.; Toma, J. S.; Rafuse, V. F.; Woolf, C. J.; Eggan, K. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 9(3):205-218; 2011.
51. Stavniichuk, R.; Drel, V. R.; Shevalye, H.; Maksimchyk, Y.; Kuchmerovska, T. M.; Nadler, J. L.; Obrosova, I. G. Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation. Exp. Neurol. 230(1):106-113; 2011.
52. Strotmeyer, E. S.; de Rekeneire, N.; Schwartz, A. V.; Resnick, H. E.; Goodpaster, B. H.; Faulkner, K. A.; Shorr, R. I.; Vinik, A. I.; Harris, T. B.; Newman, A. B. Sensory and motor peripheral nerve function and lower-extremity quadriceps strength: The health, aging and body composition study. J. Am. Geriatr. Soc. 57(11):2004-2010; 2009.
53. Sumner, C. J.; Sheth, S.; Griffin, J. W.; Cornblath, D. R.; Polydefkis, M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60(1):108-111; 2003.
54. Takashima, Y.; Era, T.; Nakao, K.; Kondo, S.; Kasuga, M.; Smith, A. G.; Nishikawa, S. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 129(7):1377-1388; 2007.
55. Terashima, T.; Kojima, H.; Fujimiya, M.; Matsumura, K.; Oi, J.; Hara, M.; Kashiwagi, A.; Kimura, H.; Yasuda, H.; Chan, L. The fusion of bone-marrow-derived proinsulinexpressing cells with nerve cells underlies diabetic neuropathy. Proc. Natl. Acad. Sci. USA 102(35):12525-12530; 2005.
56. Tesfaye, S. Recent advances in the management of diabetic distal symmetrical polyneuropathy. J. Diabetes Invest. 2(1): 33-42; 2011.
57. Tosaki, T.; Kamiya, H.; Yasuda, Y.; Naruse, K.; Kato, K.; Kozakae, M.; Nakamura, N.; Shibata, T.; Hamada, Y.; Nakashima, E.; Oiso, Y.; Nakamura, J. Reduced NGF secretion by Schwann cells under the high glucose condition decreases neurite outgrowth of DRG neurons. Exp. Neurol. 213(2):381-387; 2008.
58. Tsuji, O.; Miura, K.; Okada, Y.; Fujiyoshi, K.; Mukaino, M.; Nagoshi, N.; Kitamura, K.; Kumagai, G.; Nishino, M.; Tomisato, S.; Higashi, H.; Nagai, T.; Katoh, H.; Kohda, K.; Matsuzaki, Y.; Yuzaki, M.; Ikeda, E.; Toyama, H.; Nakamura, M.; Yamanaka, S.; Okano, H. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. USA 107(28):12704-12709; 2010.
59. Veves, A.; Young, M. J.; Manes, C.; Boulton, A. J. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care 17(10):1200-1202; 1994.
60. Vinik, A. I.; Ziegler, D. Diabetic cardiovascular autonomic neuropathy. Circulation 115(3):387-397; 2007.
61. Watabe, K.; Fukuda, T.; Tanaka, J.; Honda, H.; Toyohara, K.; Sakai, O. Spontaneously immortalized adult mouse Schwann cells secrete autocrine and paracrine growth-promoting activities. J. Neurosci. Res. 41(2):279-290; 1995.
62. Wichterle, H.; Przedborski, S. What can pluripotent stem cells teach us about neurodegenerative diseases? Nat. Neurosci. 13(7):800-804; 2010.
63. Yamada, M.; Uchida, K.; Hayashi, T.; Mine, Y.; Kawase, T. Vigorous neuronal differentiation of amplified and grafted basic fibroblast growth factor-responsive neurospheres derived from neuroepithelial stem cells. Cell Transplant. 13(4):421-428; 2004.
64. Yasuda, H.; Hotta, N.; Nakao, K.; Kasuga, M.; Kashiwagi, A.; Kawamori, R. Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan. J. Diabetes Invest. 2(2):132-139; 2011.
65. Yoshida, Y.; Yamanaka, S. Recent stem cell advances: Induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation 122(1):80-87; 2010.